Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood

被引:50
|
作者
Alam, M. Intakhab [1 ]
Baboota, Sanjula [1 ]
Ahuja, Alka [2 ]
Ali, Mushir [1 ]
Ali, Javed [1 ]
Sahni, Jasjeet K. [1 ]
机构
[1] Jamia Hamdard, Dept Pharmaceut, Fac Pharm, New Delhi, India
[2] Oman Med Coll, Dept Pharm, Muscat, Oman
关键词
DLX-NLC; ex vivo studies; in vivo studies; lipid nanocarriers; nasal permeation; NASAL ABSORPTION; IN-VIVO; DELIVERY; BIOAVAILABILITY; CAVITY; METABOLISM; TRANSPORT; SYSTEM; RATS;
D O I
10.3109/10717544.2013.822945
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was aimed to evaluate the nanostrucured lipid carriers (NLC) containing duloxetine (DLX-NLC) for intranasal infusion through the nasal cavity of rat. The in vivo nasal infusion studies were performed using Wistar rats and the amount of DLX permeated and its amount in brain and blood was estimated. The effects on absorption rate and type of drug delivery systems (nanocarriers and drug solution) for nose to brain/blood permeation were assessed. DLX was found to be permeated from the nasal cavity into the body of rat and the permeated amount was found to be more in case of DLX-NLC. Approximately 2.5-times better permeation was exhibited by DLX-NLC than DLX-solution. Appreciable amount of DLX was estimated in blood and brain and the estimated amount was higher in case of DLX-NLC. Thus the administration of NLC containing DLX through intranasal route was found to be potential method for the delivery of DLX for the treatment of depression.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [21] Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
    Mehrdadi, Soheil
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (03) : 512 - 520
  • [22] Breaking barriers: Intranasal delivery of brexpiprazole-nanostructured lipid carriers targets the brain for effective schizophrenia treatment
    Shah, Shailvi
    Patel, Amit A.
    Pandya, Vidhi
    Trivedi, Nidhi
    Patel, Samir G.
    Prajapati, Bhupendra G.
    Singh, Sudarshan
    Patel, Ravish J.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 90
  • [23] Preparation, characterization and physico-chemical properties of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC):: Their benefits as colloidal drug carrier systems
    Üner, M
    [J]. PHARMAZIE, 2006, 61 (05): : 375 - 386
  • [24] Evaluation of Brain Targeting and Mucosal Integrity of Nasally Administrated Nanostructured Carriers of a CNS Active Drug, Clonazepam
    Abdel-Bar, Hend Mohamed
    Abdel-Reheem, Amal Youssef
    Awad, Gehanne Abdel Samie
    Mortada, Nahed Daoud
    [J]. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2013, 16 (03): : 456 - 469
  • [25] Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy
    Cirri, Marzia
    Maestrini, Lavinia
    Maestrelli, Francesca
    Mennini, Natascia
    Mura, Paola
    Ghelardini, Carla
    Mannelli, Lorenzo Di Cesare
    [J]. DRUG DELIVERY, 2018, 25 (01) : 1910 - 1921
  • [26] Nanostructured Lipid Carriers for Nose to Brain Delivery Targeting CNS: Diversified Role of Liquid Lipids for Synergistic Action
    Tekade, Avinash Ramrao
    Mittha, Pradeep Sadanand
    Pisal, Charushila Sopan
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (04) : 763 - 771
  • [27] Design of experiment (DoE) of mucoadhesive valproic acid-loaded nanostructured lipid carriers (NLC) for potential nose-to-brain application
    Correia, A. C.
    Costa, I.
    Silva, R.
    Sampaio, P.
    Moreira, J. N.
    Lobo, J. M. Sousa
    Silva, A. C.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 664
  • [28] Preparation and characterization of novel nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN) containing coenzyme Q10 as potent antioxidants and antityrosinase agents
    Atapour-Mashhad, Hoda
    Tayarani-Najaran, Zahra
    Golmohammadzadeh, Shiva
    [J]. HELIYON, 2024, 10 (11)
  • [29] Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters
    Amiri, Mahtab
    Jafari, Samira
    Kurd, Masoumeh
    Mohamadpour, Hamed
    Khayati, Maryam
    Ghobadinezhad, Farbod
    Tavallaei, Omid
    Derakhshankhah, Hossein
    Malvajerd, Soroor Sadegh
    Izadi, Zhila
    [J]. ACS CHEMICAL NEUROSCIENCE, 2021, 12 (24): : 4475 - 4490
  • [30] Formulation and in-vitro drug Released Mechanism of CNS Acting Venlafaxine Nanostructured Lipid Carrier for Major Depressive Disorder
    Pimpalshende, Pankaj M.
    Gupta, Roop N.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2018, 52 (02) : 230 - 240